Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 5 (2008), Issue 12 (December)

1. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.
   Brain Behav Immun, 23(1): 92-100. [Abstract] [Full-text]
2. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis.
   Proc Natl Acad Sci U S A, 105(48): 18889-94. [Abstract] [Full-text]
3. Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.
   J Neuropathol Exp Neurol, 67(12): 1137-48. [Abstract] [Full-text]
4. Disease-modifying therapy in multiple sclerosis: update and clinical implications.
   Neurology, 71(24): S8-13. [Abstract] [Full-text]
5. Early treatment of multiple sclerosis to prevent neurologic damage.
   Neurology, 71(24): S3-7. [Abstract] [Full-text]
6. Tolerability, adherence, and patient outcomes.
   Neurology, 71(24): S21-3. [Abstract] [Full-text]
7. Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis.
   Neurology, 71(24): S14-20. [Abstract] [Full-text]
8. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
   Neurology, 71(24): 1948-54. [Abstract] [Full-text]
9. Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis.
   Neurology, 71(24): 1940-7. [Abstract] [Full-text]
10. High-field magnetic resonance imaging.
    Neuroimaging Clin N Am, 19(1): 113-28. [Abstract] [Full-text]
11. Brain imaging of multiple sclerosis: the next 10 years.
    Neuroimaging Clin N Am, 19(1): 101-12. [Abstract] [Full-text]
12. Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques.
    Neuroimaging Clin N Am, 19(1): 81-99. [Abstract] [Full-text]
13. Nonconventional optic nerve imaging in multiple sclerosis.
    Neuroimaging Clin N Am, 19(1): 71-9. [Abstract] [Full-text]
14. Functional MR imaging in multiple sclerosis.
    Neuroimaging Clin N Am, 19(1): 59-70. [Abstract] [Full-text]
15. Proton magnetic resonance spectroscopy in multiple sclerosis.
    Neuroimaging Clin N Am, 19(1): 45-58. [Abstract] [Full-text]
16. Diffusion tensor MR imaging.
    Neuroimaging Clin N Am, 19(1): 37-43. [Abstract] [Full-text]
17. Magnetization transfer MR imaging in multiple sclerosis.
    Neuroimaging Clin N Am, 19(1): 27-36. [Abstract] [Full-text]
18. MR relaxation in multiple sclerosis.
    Neuroimaging Clin N Am, 19(1): 1-26. [Abstract] [Full-text]
19. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study.
    J Urol, 181(1): 252-8. [Abstract] [Full-text]
20. Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?
    Ann Rheum Dis, 68(1): 47-50. [Abstract] [Full-text]
21. Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease.
    J Med Chem, 51(24): 7834-42. [Abstract] [Full-text]
22. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Hum Mol Genet, 18(2): 261-6. [Abstract] [Full-text]
23. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients.
    Neuroimage, 44(3): 769-76. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.